Exelon (NASDAQ:EXC) reported quarterly earnings of $0.43 per share which met the analyst consensus estimate. This is a 52.22 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $4.67 billion which beat the analyst consensus estimate of $4.11 billion by 13.55 percent. This is a 51.55 percent decrease over sales of $9.63 billion the same period last year.
Apollo Endosurgery Q2 EPS $(0.26) Misses $(0.22) Estimate, Sales $19.31M Beat $18.39M Estimate
Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.22) by 18.18 percent. This is a 136.36 percent decrease over losses of $(0.11) per share
